A survey of clinical practice of lung transplantation in North America

Chest

Volumn 125, Issue 4, 2004, Pages 1224-1238

  Levine, Stephanie M ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Acute rejection; Bronchiolitis obliterans; Chronic rejection; Cytomegalovirus; Infection; Lung transplantation; Survey

Indexed keywords

ACICLOVIR; AMPHOTERICIN; AZATHIOPRINE; BISPHOSPHONIC ACID DERIVATIVE; CALCINEURIN INHIBITOR; CALCIUM; CORTICOSTEROID; CYCLOSPORIN A; CYTOMEGALOVIRUS ANTIBODY; FLUCONAZOLE; GANCICLOVIR; IMMUNOSUPPRESSIVE AGENT; ITRACONAZOLE; LYMPHOCYTE ANTIBODY; METHOTREXATE; METHOXSALEN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NITRIC OXIDE; OKT 3; PREDNISONE; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY; VALGANCICLOVIR; VITAMIN D;

ACUTE GRAFT REJECTION; ANTIMICROBIAL THERAPY; BODY WEIGHT; BRONCHIOLITIS; BRONCHOSCOPY; CHRONIC GRAFT REJECTION; CLINICAL PRACTICE; CYTOMEGALOVIRUS INFECTION; DATA BASE; EXERCISE; GRAFT PRESERVATION; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; LIVING DONOR; LUNG DISEASE; LUNG TRANSPLANTATION; MAINTENANCE THERAPY; MYCOSIS; NORTH AMERICA; OSTEOPENIA; OSTEOPOROSIS; OUTCOMES RESEARCH; PATIENT SELECTION; POSTOPERATIVE CARE; POSTOPERATIVE INFECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; PUVA; QUESTIONNAIRE; REOPERATION; REPERFUSION INJURY; REVIEW; UNITED STATES; VIRUS INFECTION;

EID: 11844299894     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.125.4.1224     Document Type: Article

References (20)

1. The American Society for Transplant Physicians (ASTP)/. American Thoracic Society (ATS)/European Respiratory Society (ERS)/International Society for Heart and Lung Transplantation (ISHLT). International guidelines for the selection of lung transplant candidates. Am J Respir Crit Care Med 1998; 158:335-339
2. Nunley DR, Grgurich W, Iacono AT, et al. Allograft colonization and infections with Pseudomonas in cystic fibrosis lung transplant recipients. Chest 1998; 113:1235-1243
3. Aris RM, Gilligan PH, Neuringer IP, et al. The effects of panresistant bacteria in cystic fibrosis patients on lung transplant outcome. Am J Respir Crit Med 1997; 155:1699-1704
4. Chaparro C, Maurer J, Gutierrez C, et al. Infection with Burkholderia cepacia in cystic fibrosis: outcome following lung transplantation. Am J Respir Crit Care Med 2001; 163:43-48
5. Liou TG, Adler FR, Fitzsimmons SC, et al. Predictive 5-year survivorship model of cystic fibrosis. Am J Epidemiol 2001; 153:345-352
6. Levine SM, Jenkinson SG, Bryan CL, et al. Ventilation-perfusion inequalities during graft rejection in patients undergoing single lung transplantation for primary pulmonary hypertension. Chest 1992; 101:401-405
7. Gammie JS, Keenan RJ, Pham SM, et al. Single- versus double-lung transplantation for pulmonary hypertension. J Thorac Cardiovasc Surg 1998; 115:397-402
8. Conte JV, Borja MJ, Patel CB, et al. Lung transplantation for primary and secondary pulmonary hypertension. Ann Thorac Surg 2001; 72:1673-1679
9. Kanasky WF Jr, Anton SD, Rodrigue JR, et al. Impact of body weight on long term survival after lung transplantation. Chest 2002; 121:401-406
10. Spira A, Gutierrez C, Chaparro C, et al. Osteoporosis and lung transplantation: a prospective study. Chest 2000; 117:476-481
11. Aris RM, Neuringer IP, Weiner MA, et al. Severe osteoporosis before and after lung transplantation. Chest 1996; 109:1176-1183
12. Shane E, Silverberg SJ, Donovan D, et al. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease. Am J Med 1996; 101:262-269
13. Meade MO, Granton JT, Matte-Martyn A, et al. A randomized trial of inhaled nitric oxide to prevent ischemia-reperfusion injury after lung transplantation. Am J Respir Crit Care Med 2003; 167:1483-1489
14. Kemming GI, Merkel MJ, Schallerer A, et al. Inhaled nitric oxide (NO) for the treatment of early allograft failure after lung transplantation. Intensive Care Med 1998; 24:1173-1180
15. Meyer KC, Love RB, Zimmerman JJ. The therapeutic potential of nitric oxide in lung transplantation. Chest 1998; 113:1360-1371
16. The International Society of Heart and Lung Transplantation. Heart/Lung Transplant Registry. Available at: www.ishlt.org. Accessed March 9, 2003
17. Kukafaka DS, O'Brien GM, Furukawa S, et al. Surveillance bronchoscopy in lung transplant recipients. Chest 1997; 111:377-381
18. Valentine VG, Taylor DE, Dhillon GS, et al. Success of lung transplantation without surveillance bronchoscopy. J Heart Lung Transplant 2002; 21:319-326
19. Gross CR, Savik K, Bolman RM, et al. Long-term health status and quality of life outcomes of lung transplant recipients. Chest 1995; 108:1587-1593
20. Limbos MM, Joyce DP, Chan CK, et al. Physiological functioning and quality of life in lung transplant candidates and recipients. Chest 2000; 118:408-416